← Back to Nectar Lifesciences Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

NECLIFEPharmaceuticals

Nectar Lifesciences Ltd — Financial Ratios & Key Metrics

₹9.30

-7.74%

P/E RatioN/AxIndustry: 31.77x

ROE-11.23%Return on equity

ROCE-5.36%Return on capital

Debt/Equity0.64Low debt

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹390.66 (Cr)

Sales Growth 5Y

-6.77%

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

5.49%

📉

Price Returns

1 Month

+12.31%

3 Months

+19.89%

6 Months

-28.49%

1 Year

-48.08%

52W Low

₹10

Current

₹9

52W High

₹28

-3% of 52-week range — Near lows

🔬

Technical Indicators

Oversold

Selling pressure is heavy — potential reversal zone.

SMA 50

₹13

▼ Price below SMA 50 — Bearish

SMA 200

₹16

▼ Long-term downtrend

Volume Signal

241% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Nectar Lifesciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.